← Eichor
Study identifier: NCT05989802 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)

Condition: Tuberculosis · Diagnostics · Global Health  ·  Sponsor: University of California, San Francisco

PhaseNA
Planned participants2100
Who can joinAll sexes, N/A to 65 Years
Healthy volunteersYes

About this study

Every year there are an estimated 230,000 childhood deaths from TB. There is an urgent need for novel tests for TB diagnosis in children under 15 years. The Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and the Assessing Diagnostics at Point-of-care for Tuberculosis in children (ADAPT for Kids) studies seek to reduce the burden of TB worldwide by evaluating faster, simpler, and less expensive TB triage and diagnostic tests for use in children.

This description comes directly from the study's public registry record.

Talk to the study team

Devan Jaganath, MD  ·  415-514-4692  ·  devan.jaganath@ucsf.edu

Brittney Sweetser, MPH  ·  bsweetse@hs.uci.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Instituto Nacional de SaúdeMaputo, MozambiqueRecruiting
Dora Nginza HospitalCape Town, South AfricaNot Yet Recruiting
Mulago National Referral HospitalKampala, UgandaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05989802